Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Công thức hóa học
C22H28N2O2
Monoisotopic mass
352.21507815
InChI
InChI=1S/C22H28N2O2/c1-24-16-6-5-8-19(24)13-10-17-7-3-4-9-21(17)23-22(25)18-11-14-20(26-2)15-12-18/h3-4,7,9,11-12,14-15,19H,5-6,8,10,13,16H2,1-2H3,(H,23,25)
InChI Key
InChIKey=PJWPNDMDCLXCOM-UHFFFAOYSA-N
IUPAC Name
4-methoxy-N-{2-[2-(1-methylpiperidin-2-yl)ethyl]phenyl}benzamide
Traditional IUPAC Name
encainide
SMILES
COC1=CC=C(C=C1)C(=O)NC1=CC=CC=C1CCC1CCCCN1C
pKa (strongest acidic)
12.37
pKa (Strongest Basic)
9.48
Refractivity
107.77 m3·mol-1
Dược Lực Học :
Used to treat irregular heartbeats, encainide decreases excitability, conduction velocity, and automaticity as a result of slowed atrial, atrioventricular (AV) nodal, His-Purkinje, and intraventricular conduction. It causes a slight but significant prolongation of refractory periods in these tissues. The greatest effect is on the His-Purkinje system. Encainide decreases the rate of rise of the action potential without markedly affecting its duration.
Cơ Chế Tác Dụng :
All drug products containing encainide hydrochloride. Encainide hydrochloride, formerly marketed as Enkaid capsules, was associated with increased death rates in patients who had asymptomatic heart rhythm abnormalities after a recent heart attack. The manufacturer of Enkaid capsules voluntarily withdrew the product from the US market on December 16, 1991.
Encainide is a sodium channel blocker, binding to voltage gated sodium channels. It stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses. Ventricular excitability is depressed and the stimulation threshold of the ventricle is increased during diastole.
Dược Động Học :
▧ Route of Elimination :
A radiolabeled dose of encainide is excreted in approximately equal amounts in the urine and feces.
▧ Half Life :
1-2 hours
Chỉ Định :
Encainide is a class Ic antiarrhythmic agent which was used for management of irregular heartbeats, such as atrial fibrillation, atrial flutter, ventricular tachycardia, and ventricular fibrillation.
Tương Tác Thuốc :
-
Cisapride
Increased risk of cardiotoxicity and arrhythmias
Tài Liệu Tham Khảo Thêm
National Drug Code Directory